Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Value of Vitrectomy Combined With Sodium Fluorescein Angiography in the Diagnosis and Treatment of Vascular Retinal Diseases

NCT06343961 is registered in ClinicalTrials.gov with Jie Zhong as lead sponsor.

NCT NCT06343961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06343961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Value of Vitrectomy Combined With Sodium Fluorescein Angiography in the Diagnosis and Treatment of Vascular Retinal Diseases
Lead sponsor
Jie Zhong
Phase
Not applicable
Overall status
Unknown status
Start date
April 18, 2024
Completion date
December 31, 2025
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy, retinal vasculitis, retinal vein occlusion, vascular retinopathy of left eye (disorder), vascular retinopathy of right eye (disorder), vitreous hemorrhage